Table 3.
Bone Marrow Vessels Density during Bortezomib Trial in 15 Patients who had Serial Bone Marrow Specimens Available for Review
Case | Bortezomib dose mg/m2 | Number of vessels (×10−3μ2) | Change from baseline (%) | |
---|---|---|---|---|
Baseline | Final | |||
1 | 0.8 | 1.41 | 2.54 | 80.1 |
2 | 0.8 | 2.33 | 2.78 | 19.3 |
3 | 0.8 | 2.66 | 2.17 | −18.4 |
4 | 1 | 3.32 | 3.02 | −9.0 |
5 | 1 | 2.17 | 2.14 | −1.4 |
6 | 1.3 | 1.30 | 2.49 | 91.5 |
7 | 1.3 | 2.66 | 1.40 | −47.4 |
8 | 1.3 | 3.65 | 1.79 | −50.9 |
9 | 1.3 | 1.92 | 2.43 | 26.5 |
10 | 1.3 | 4.09 | 3.20 | −21.8 |
11 | 1.3 | 2.76 | 2.77 | 0.4 |
12 | 1.3 | 4.56 | 3.15 | −30.9 |
13 | 1.3 | 5.93 | 3.41 | −42.5 |
14 | 1.3 | 2.06 | 2.30 | 11.6 |
15 | 1.3 | 3.96 | 2.54 | −36.1 |
Median | 2.66 | 2.53 | −9.03 |